M Cash Integrasi Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? M Cash Integrasi Tbk. trades at Rp318 (market cap 269.06B, 9.62M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: M Cash Integrasi Tbk. is the larger of the two by market cap, and M Cash Integrasi Tbk. is more actively traded (9.62M versus 187.4K). Which is the better fit depends on your goals.
| MCAS | OBAT | |
|---|---|---|
Market Cap | 269.06B | 164.65B |
Volume | 9.62M | 187.4K |
Lot | 96.18K | 1.87K |
Turnover | 3.06B | 44.35M |
Average Price | 318.11 | 236.67 |
Value | 3.06B | 44.35M |
Indicative Equilibrium Price | 318 | 242 |
Indicative Equilibrium Volume | 3.98K | 500 |
Trailing returns across standard periods
Latest headlines on both assets
PT M Cash Integrasi Tbk (the Company) was established based on Notarial Deed No. 1 of UkonKrisnajaya, S.H., Sp.N. dated June 1, 2010.
Read more on MCAS →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →